The authors thank Christine A. Curcio, PhD, University of Alabama at Birmingham, for the insightful comments on the manuscript.
Supported by German Research Foundation Grant No. FL658/4-1 and FL658/4-2 to MF for the DSGA study. AO was supported by Alexander von Humboldt Foundation (Bonn, Germany) and Alcon Japan (Tokyo, Japan). ML, BONFOR GEROK Program of the Faculty of Medicine, University of Bonn, Grant No. O-137.0020. MP, BONFOR GEROK Program of the Faculty of Medicine, University of Bonn, Grant No. O-137.0022.
Disclosure: M. Oishi, Carl Zeiss MediTec (F), Heidelberg Engineering (F), Optos (F); A. Oishi, Carl Zeiss MediTec (F), Heidelberg Engineering (F), Optos (F), Alcon Japan (F), Bayer (F), Novartis (F); M. Lindner, Allergan (R), Carl Zeiss MediTec (F, I), Fresenius Medical Care (I), Genentech/Roche (F), Heidelberg Engineering (F), Optos (F); M. Pfau, Carl Zeiss MediTec, (F) Heidelberg Engineering (F), Optos (F); S. Schmitz-Valckenberg, Alcon/Novartis (F, C), Allergan (F, R), Bayer (F, R), Formycon (F), Heidelberg Engineering (F, R), Optos (F); F.G. Holz, Bayer (F, R, C), Bioeq (F, C), Genentech/Roche (F, R, C), NightstarX (F), Optos (F), Carl Zeiss MediTec (F, R) Acucela (F, C), Boehringer-Ingelheim (C), Thea (C), Allergan (F, R), Novartis (F, R, C), Heidelberg Engineering (F, R, C); M. Fleckenstein, Allergan (F, R), Carl Zeiss MediTec (F), Formycon (F), Heidelberg Engineering (F, R), Genentech/Roche (F, R, C), Alcon/Novartis (F, C), Bayer (F, R), Optos (F), P